CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market sale See Remarks sold 68,204 shares at an average $12.78 ($871,380)
- 4 Open-market sale Director sold 10,313 shares at an average $13.35 ($137,664)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale See Remarks sold 6,104 shares at $11.62 ($70,928)
- 4 Open-market sale Chief Marketing Officer sold 6,495 shares at $9.73 ($63,166)
- 4 Open-market sale See Remarks sold 37,972 shares at $9.73 ($369,293)
- 4 Open-market sale See Remarks sold 10,192 shares at $9.73 ($99,121)
- 4 Open-market sale See Remarks sold 10,192 shares at $9.73 ($99,121)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award See Remarks acquired 214,286 shares (grant or award)
- 4 Grant or award See Remarks acquired 53,571 shares (grant or award)
- 4 Grant or award See Remarks acquired 53,571 shares (grant or award)
Page 14 of 28 · 558 filings